Infection after transrectal ultrasonography-guided prostate biopsy: Increased relative risks after recent international travel or antibiotic use

BJU International

Volumn 109, Issue 12, 2012, Pages 1781-1785

  Patel, Uday ^a   Dasgupta, Prokar ^a   Amoroso, Peter ^a   Challacombe, Ben ^a   Pilcher, James ^a   Kirby, Roger ^a  

^a Prostate Centre   (United Kingdom)

Author keywords

biopsy; complications; drug resistance; E. coli; infection; prostate

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFRADINE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; PROSTATE SPECIFIC ANTIGEN; TRIMETHOPRIM;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RISK FACTOR; SEPSIS; TRANSRECTAL ULTRASONOGRAPHY GUIDED PROSTATE BIOPSY; TRAVEL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSTATE; RISK FACTORS; SEPSIS; TRAVEL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84861576984     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10561.x     Document Type: Article

References (22)

1. Undertaking a transrectal ultrasound guided biopsy of the prostate. Available at:. Accessed May 2010
2. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH,. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-30
3. Feliciano J, Teper E, Ferrandino M, et al,. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952-5
4. Gale J,. Prostate cancer exam deaths from 'superbugs' spurs inquiry into cancer tests. Available at:. Accessed May 2011
5. So A, Furlong M, Heddini A,. Globalisation and antibiotic resistance. BMJ 2010; 341: c5116
6. Nam RK, Saskin R, Lee Y, et al,. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963-8
7. Carlson WH, Bell DG, Lawen JG, Rendon RA,. Multi-drug resistant E. coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies-three cases including one death. Can J Urol 2010; 17: 5135-7
8. Chen YH, Hsueh PR, Badal RE, et al,. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011; 62: 280-91
9. Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA,. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 2007; 13: 1640-6
10. Van de Sande-Bruinsma N, Grundmann H, et al,. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30
11. Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, Zechiedrich L,. Increased fluoroquinolone resistance with time in Escherichia coli from >17 000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 2008; 8: 4
12. Bean DC, Krahe D, Wareham DW,. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008; 7: 13
13. Raum E, Lietzau S, von Baum H, Marre R, Brenner H,. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect 2008; 14: 41-8
14. Kennedy K, Collignon P,. Colonisation with Escherichia coli resistant to 'critically important' antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010; 29: 1501-6
15. Tängdén T, Cars O, Melhus A, Löwdin E,. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8
16. Orskov F, Sack RB, Orskov I, Froelich JL,. Changing fecal Escherichia coli flora during travel. Eur J Clin Microbiol 1984; 3: 306-9
17. Murray BE, Mathewson JJ, DuPont HL, Ericsson CD, Reves RR,. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 515-8
18. Batura D, Rao GG, Bo Nielsen P, Charlett A,. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 2011; 107: 760-4
19. Tal R, Livne PM, Lask DM, Baniel J,. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003; 169: 1762-5
20. Patel U, Kirby R,. Infections after prostate biopsy and antibiotic resistance. BJU Int 2008; 101: 1201-2
21. Chappell B, O'Brien T,. Infections after prostate biopsy and antibiotic resistance. BJU Int 2009; 103: 409
22. Merrick GS, Taubenslag W, Andreini H, et al,. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008; 101: 1524-9